Pulmonary Stents Market Size & Growth Forecast 2026–2035, By Segments (Product, Type, Material), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growoth Outlook
Pulmonary Stents Market size was assessed at USD 238.08 Million in 2025 and is poised to grow at a 5% CAGR between 2026 and 2035, attaining USD 387.81 Million by 2035. The industry revenue for 2026 is calculated at USD 248.37 million.
Get more details on this report
Request Free Sample ReportPulmonary Stents Market Intelligence Snapshot
Regional Market Dynamics
- North America accounted for 46.31% of the market in 2025, supported by advanced interventional care infrastructure, specialized hospitals, and consistent use of stent-based pulmonary procedures.
- Asia Pacific is projected to grow at a 5.7% CAGR as healthcare systems expand interventional capabilities, improve access to specialized respiratory care, and increase minimally invasive pulmonary procedures.
Segment Momentum
- Balloon-expandable Stents captured a 56.07% share in 2025, supported by precise deployment, controlled placement, and strong physician familiarity in pulmonary procedures where procedural accuracy is essential.
- Laryngeal Stents are expanding quickly as demand increases for specialized upper-airway interventions requiring targeted support in anatomically complex laryngeal conditions where conventional stents are less suitable.
Market Expansion Drivers
- Rising prevalence of COPD and lung cancer increasing demand for minimally invasive airway management devices.
- Advancements in biodegradable, drug-eluting, and 3D-printed stent technologies improving patient outcomes.
- Growing adoption of minimally invasive pulmonary interventions expanding stent-based treatment usage.
Leading Market Participants
Global Market Forecast Snapshot
Market Outlook
Prominent companies in the pulmonary stents market include Boston Scientific Corporation (United States), Cook Medical LLC (United States), ENDO-FLEX GmbH (Germany), Efer Endoscopy (France), E. Benson Hood Laboratories, Inc. (United States), Merit Medical Systems, Inc. (United States), Micro-Tech Endoscopy USA Inc. (United States), Taewoong Medical Co., Ltd. (South Korea), Olympus Corporation (Japan), Medtronic plc (Ireland).Regional and Segment Outlook
North AmericaMarket Growth Drivers and Industry Trends
A growing burden of COPD and lung cancer is steadily increasing the number of patients who develop airway obstruction, compression, or narrowing that requires rapid symptom relief and sustained airway patency. In the pulmonary stents market, this translates into stronger procedure volumes in bronchoscopy-led interventions, particularly for patients who are poor candidates for open surgery or need palliative airway support during cancer care. Physicians and hospitals tend to favor minimally invasive airway management devices when respiratory distress, recurrent stenosis, or tumor-related obstruction demands immediate functional improvement, which reinforces market demand for pulmonary stents as part of routine interventional pulmonology practice.
Advancements in biodegradable, drug-eluting, and 3D-printed stent technologies improving patient outcomes
Innovation in biodegradable, drug-eluting, and 3D-printed designs is reshaping product selection in the pulmonary stents market by addressing long-standing clinical concerns such as migration, granulation tissue formation, restenosis, and fit within complex airway anatomies. When newer stents are better tailored to lesion characteristics or patient-specific airway structures, clinicians gain greater confidence in using them for cases where conventional options may have delivered inconsistent outcomes. This is influencing market adoption through a shift toward higher-value devices that support more precise placement, reduced complication management, and broader use in specialized centers managing complex benign and malignant airway disease.
Growing adoption of minimally invasive pulmonary interventions expanding stent-based treatment usage
As bronchoscopy-based and other minimally invasive pulmonary interventions become more embedded in respiratory and thoracic care pathways, pulmonary stents are being used more often as a practical therapeutic component rather than a last-resort option. The pulmonary stents market benefits when hospitals expand interventional pulmonology capabilities, train specialists in advanced airway procedures, and integrate stenting into treatment algorithms for stenosis, fistulas, and malignant obstruction. This clinical shift shortens the path from diagnosis to intervention, increases physician familiarity with stent deployment, and supports market expansion through more routine use in centers seeking less invasive ways to restore airway function.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising prevalence of COPD and lung cancer increasing demand for minimally invasive airway management devices | 2.30% | High | North America, Europe | High | Near Term |
| Advancements in biodegradable, drug-eluting, and 3D-printed stent technologies improving patient outcomes | 2.00% | High | North America, Asia Pacific | High | Mid Term |
| Growing adoption of minimally invasive pulmonary interventions expanding stent-based treatment usage | 1.70% | Moderate | Asia Pacific, Latin America | Medium | Mid Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America held the leading position in 2025, accounting for a 46.31% share of the pulmonary stents market. This leadership is backed by the region’s established interventional care infrastructure, broad availability of advanced diagnostic and catheter-based treatment pathways, and the concentration of specialized hospitals capable of managing complex pulmonary vascular and airway conditions. In practice, these factors support higher procedure volumes, earlier referral into specialist care, and more consistent use of stent-based interventions where clinically appropriate, helping the region maintain its current market position.
Asia Pacific is projected to expand at a 5.7% CAGR over the forecast period, with growth in the pulmonary stents market being impelled by improving access to specialized respiratory and cardiovascular care and the ongoing expansion of interventional treatment capabilities across major healthcare centers. Adoption is accelerating as more patients are diagnosed and treated within hospital systems that are increasingly equipped to perform minimally invasive procedures, while broader healthcare development is creating a larger base for stent utilization in routine clinical practice.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Engineering-Based Device QualityGermany emphasizes pulmonary stents that deliver reliable performance and compatibility with advanced interventional pulmonology procedures. Medical device developers collaborate closely with healthcare providers to refine stent design and procedural outcomes.
France 🇫🇷
Specialist Respiratory CareFrance integrates pulmonary stents into specialist respiratory treatment programs supported by multidisciplinary clinical expertise. Hospitals focus on selecting devices that enhance procedural effectiveness while maintaining consistent patient care standards.
Italy 🇮🇹
Hospital Procedure OptimizationItaly advances pulmonary stent adoption through hospital-based respiratory intervention programs emphasizing procedural efficiency and clinical collaboration. Physicians increasingly incorporate modern stent technologies into comprehensive airway disease management strategies.
Japan 🇯🇵
Complex Airway ManagementJapan utilizes pulmonary stents in managing complex airway conditions while emphasizing precision placement and long-term patient follow-up. Clinical practice supports adoption of technologies that improve procedural efficiency and patient comfort.
South Korea 🇰🇷
Minimally Invasive ExpansionSouth Korea continues expanding pulmonary stent utilization through modern respiratory care and interventional pulmonology services. Healthcare providers prioritize innovative stent technologies that support less invasive treatment pathways for airway disorders.
United States 🇺🇸
Advanced Interventional CareThe U.S. pulmonary stents market prioritizes minimally invasive respiratory interventions supported by specialized pulmonary and thoracic care centers. Hospitals continue adopting advanced stent technologies designed to improve procedural precision and patient management.
Segment Leadership and Growth Trends
Pulmonary Stents Market Share (%), Product, 2025
Go beyond the chart, access full insights & data tables
Request Free Sample ReportBalloon-expandable Stents held a 56.07% share of the pulmonary stents market in 2025, reflecting their established role in cases where controlled placement and precise deployment are critical. Their leadership is supported by physician familiarity and the practical need for accurate stent expansion in anatomically sensitive pulmonary pathways, where procedural control can directly influence treatment outcomes. This combination of clinical predictability and routine use in interventional settings continues to sustain the segment’s leading share in the pulmonary stents market.
Self-expandable Stents are emerging as the fastest-growing segment in the pulmonary stents market as clinicians increasingly value solutions that can adapt more effectively to variable airway anatomy and ongoing luminal changes. Their growth momentum is being shaped by practical treatment requirements in more complex or dynamic obstruction cases, where flexibility after placement can offer an advantage over more rigid deployment approaches. Relative to alternatives, this ability to conform within challenging airway conditions is the key factor strengthening demand for Self-expandable Stents.
Type Segment Analysis: Tracheobronchial Stents (Largest Segment) vs Laryngeal Stents (Fastest-Growing Segment)
With a 69.24% share in 2025, Tracheobronchial Stents represented the dominant type segment in the pulmonary stents market due to their broad application in managing airway narrowing and obstruction across the trachea and bronchi. Their continued leadership is tied to the higher procedural relevance of these airway regions in pulmonary intervention, where maintaining patency is often central to symptom relief and respiratory support. The segment’s strong share reflects this consistent clinical demand and its entrenched use in routine airway management.
Laryngeal Stents are the fastest-growing type segment in the pulmonary stents market, encouraged by rising attention to upper-airway preservation and the need for targeted support in anatomically complex laryngeal conditions. Growth is being reinforced by the practical shift toward more specialized airway interventions, where standard tracheobronchial solutions are not sufficient for laryngeal placement requirements. This increasing need for segment-specific treatment approaches is helping Laryngeal Stents expand faster than other type categories.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Product | Self-expandable Stents, Balloon-expandable Stents | Balloon-expandable Stents | Self-expandable Stents |
| Type | Tracheobronchial Stents, Laryngeal Stents | Tracheobronchial Stents | Laryngeal Stents |
| Material | Metal, Silicon, Hybrid | Metal | Silicon |
Competitive Landscape and Market Positioning
1. Boston Scientific Corporation (United States)
2. Cook Medical LLC (United States)
3. ENDO-FLEX GmbH (Germany)
4. Efer Endoscopy (France)
5. E. Benson Hood Laboratories Inc. (United States)
6. Merit Medical Systems Inc. (United States)
7. Micro-Tech Endoscopy USA Inc. (United States)
8. Taewoong Medical Co. Ltd. (South Korea)
9. Olympus Corporation (Japan)
10. Medtronic plc (Ireland)
In the pulmonary stents market, innovation is strongly driven by the need for improved airway support solutions for complex respiratory conditions. Advancements in material flexibility and biocompatibility are enhancing procedural outcomes. Increasing clinical demand for minimally invasive interventions is further accelerating product refinement. The pulmonary stents market continues to evolve with a focus on improving patient recovery and long-term implant performance.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| No companies available. | |||||||
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Peytant | Oct-24 | Peytant received FDA De Novo clearance for the AMStent Tracheobronchial Covered Stent System, designed for malignant tracheobronchial strictures in adult patients. The system integrates a minimally invasive delivery platform and amnion-derived covering intended to reduce migration, inflammation, and mucus accumulation, supporting improved palliative airway management outcomes. |
| Renata Medical | Aug-24 | Renata Medical obtained FDA approval for its Minima Growth Stent, designed for neonates, infants, and young children with congenital heart defects. The stent can expand as patients grow, addressing long-standing limitations in pediatric vascular and pulmonary intervention technologies. |
| Boston Scientific Corporation | Jun-22 | Boston Scientific acquired a 64% majority stake in M.I.Tech Co., Ltd., a Korean medical device company specializing in self-expanding metal stents for endoscopic and urologic applications. The acquisition expands Boston Scientific’s stent technology portfolio and strengthens its position in minimally invasive device markets. |
| Micro-Tech Endoscopy | Feb-22 | Micro-Tech Endoscopy launched a self-expanding tracheobronchial nitinol Y-stent designed for treating malignant tumors at the tracheobronchial carina. The device enhances treatment flexibility in airway obstruction management and expands minimally invasive stenting options for complex pulmonary conditions. |
| Cook Group | Jan-22 | Cook Group received FDA Breakthrough Device designation for a novel drug-eluting stent intended for below-the-knee vascular procedures. The designation supports accelerated development and regulatory engagement for advanced stent technologies targeting complex peripheral vascular disease. |
| Micro-Tech (Nanjing) Co., Ltd. | Jul-18 | Micro-Tech (Nanjing) Co., Ltd. established Micro-Tech USA, Inc. as a wholly owned subsidiary in the United States to strengthen its commercial and distribution footprint. The expansion enhances direct market access for its pulmonary and endoscopic device portfolio in the U.S. healthcare market. |
Explore This Report
Click a section of the wheel — or its numbered marker — to preview the custom segmentation, custom table of contents, or related reports available for this market.
Pulmonary Stents Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| No segment data available. | |
Pulmonary Stents Market — report.custom
| Custom Chapter | Custom Details | ||
|---|---|---|---|
| No custom TOC data available. | |||
Need a different cut of the data?
Request Custom ResearchHow much revenue does the pulmonary stents market generate?
What is the forecasted size of the pulmonary stents industry?
How is the rising burden of COPD and lung cancer influencing demand for pulmonary stents?
How are innovations in stent design and minimally invasive procedures shaping pulmonary stent adoption?
Why do Balloon-expandable Stents dominate the pulmonary stents market?
Why are Laryngeal Stents the fastest-growing type in the pulmonary stents market?
What supports North America's leadership in the pulmonary stents market?
Why is Asia Pacific becoming the fastest-growing pulmonary stents market?
What are the prominent companies operating in the pulmonary stents landscape?
Our Clients
"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."
"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."
"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source Category | Research Sources | Purpose |
|---|---|---|
| Government Publications | Government agencies, statistical departments, regulatory bodies | Industry statistics, regulatory insights, and policy analysis |
| Company Disclosures | Annual reports, investor presentations, financial filings | Company performance, business strategy, and market positioning |
| Trade Associations | Industry associations and professional organizations | Industry developments, standards, and market perspectives |
| Technical Literature | Research papers, technical publications, academic journals | Technology developments and technical validation |
| Patent Analysis | Patent databases and intellectual property publications | Innovation trends, technology activity, and competitive research |
| Industry Databases | Established research databases and market intelligence resources | Market benchmarking, historical data, and industry analysis |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization